The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 424-425 , February 2009

Early peanut consumption: Postpone or promote?

  • A. Wesley Burks, MD

      Affiliations

    • Corresponding Author InformationReprint requests: A. Wesley Burks, MD, Professor and Chief, Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC 27710.

Received 8 December 2008 ,Revised 16 December 2008 ,Accepted 16 December 2008.

References 

  1. Grundy J, Matthews S, Bateman B, Dean T, Arshad SH. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J Allergy Clin Immunol. 2002;110:784–789
  2. Sicherer SH, Munoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol. 2003;112:1203–1207
  3. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107:191–193
  4. Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119:1016–1018
  5. Committee on Toxicity. COT report on peanut allergy (1998). Available at: http://cot.food.gov.uk/cotreports/cotwgreports/cotpeanutallergy. Accessed September 20, 1998.
  6. American Academy of Pediatrics. Hypoallergenic infant formulas. Pediatrics. 2000;106:346–349
  7. Du Toit G, Katz YK, Sasieni P, Mesher D, Maleki SJ, Fisher HR, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol. 2009;In press
  8. Fox AT, Sasieni P, Du Toit G, Syed H, Lack G. Household peanut consumption as a risk factor for the development of peanut allergy. J Allergy Clin Immunol. 2009;123:417–423
  9. Dalal I, Binson I, Reifen R, Amitai Z, Shohat T, Rahmani S, et al. Food allergy is a matter of geography after all: sesame as a major cause of severe IgE-mediated food allergic reactions among infants and young children in Israel. Allergy. 2002;57:362–365
  10. Sicherer SH, Burks AW, Sampson HA. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics. 1998;102:e6
  11. Agostoni C, Decsi T, Fewtrell M, Goulet O, Kolacek S, Koletzko B, et al. ESPGHAN Committee on Nutrition. Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2008;46:99–110
  12. Greer FR, Sicherer SH, Burks AW. American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. 2008;121:183–191
  13. Zutavern A, von Mutius E, Harris J, Mills P, Moffatt S, White C, et al. The introduction of solids in relation to asthma and eczema. Arch Dis Child. 2004;89:303–308
  14. Filipiak B, Zutavern A, Koletzko S, von Berg A, Brockow I, Grübl A, et al. GINI-Group. Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study. J Pediatr. 2007;151:352–358
  15. Levy Y, Broides A, Segal N, Danon YL. Peanut and tree nut allergy in children: role of peanut snacks in Israel?. Allergy. 2003;58:1206–1207
  16. Kopper RA, Odum NJ, Sen M, Helm RM, Stanley JS, Burks AW. Peanut protein allergens: the effect of roasting on solubility and allergenicity. Int Arch Allergy Immunol. 2005;136:16–22
  17. Hourihane JO, Aiken R, Briggs R, Gudgeon LA, Grimshaw KE, DunnGalvin A, et al. The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J Allergy Clin Immunol. 2007;119:1197–1202
  18. Immune Tolerance Network. About the LEAP Study. 2006. Available at: http://www.leapstudy.com/study_about.html. Accessed December 14, 2007.

 Disclosure of potential conflict of interest: A. W. Burks is a consultant for ActoGeniX NV, Intelliject, McNeil Nutritionals, and Novartis; owns stock in Allertein and Mast Cell, Inc; has served on an advisory board or expert panel for Dannon Co Probiotics and Nutricial; has received research funding from the National Institutes of Health, the Food Allergy and Anaphylaxis Network, Gerber, and the Wallace Foundation; and has provided legal consultation or expert witness testimony on the topic of food allergy.

PII: S0091-6749(08)02436-6

doi: 10.1016/j.jaci.2008.12.015

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 424-425 , February 2009

Article Tools